Clinical and imaging findings in Parkinson disease associated with the A53E SNCA mutation

Neurology: Genetics

Volumn 1, Issue 4, 2015, Pages

  Martikainen, Mika H ^a   Päivärinta, Markku ^a   Hietala, Marja ^a   Kaasinen, Valtteri ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMANTADINE; DOPAMINE TRANSPORTER; IODINE 123; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR; PRAMIPEXOLE;

ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BODY POSTURE; BRADYKINESIA; BRAIN DEPTH STIMULATION; CASE REPORT; CAUDATE NUCLEUS; CERVICAL SPINE RADIOGRAPHY; CLINICAL FEATURE; CONSTIPATION; DEPRESSION; DYSARTHRIA; EXON; FEMALE; FINN (CITIZEN); FOLLOW UP; GAIT DISORDER; HAND PARESTHESIA; HETEROZYGOSITY; HUMAN; LEVODOPA-INDUCED DYSKINESIA; LOW DRUG DOSE; MIDDLE AGED; MUSCLE RIGIDITY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; OUTPATIENT DEPARTMENT; PANIC; PARKINSON DISEASE; POINT MUTATION; PRIORITY JOURNAL; PUTAMEN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPASTIC GAIT; SUBTHALAMIC NUCLEUS; TREATMENT RESPONSE; TREMOR; UNIFIED PARKINSON DISEASE RATING SCALE;

EID: 85042912997     PISSN: None     EISSN: 23767839     Source Type: Journal    
DOI: 10.1212/NXG.0000000000000027     Document Type: Article

References (11)

1. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047.
2. Krüger R, Kuhn W, Müller T, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 1998;18:106-108.
3. Zarranz JJ, Alegre J, Gómez-Esteban JC, et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 2004;55:164-173.
4. Proukakis C, Dudzik CG, Brier T, et al. A novel α-synuclein missense mutation in Parkinson disease. Neurology 2013;80: 1062-1064.
5. Appel-Cresswell S, Vilarino-Guell C, Encarnacion M, et al. Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease. Mov Disord 2013; 28:811-813.
6. Lesage S, Anheim M, Letournel F, et al. G51D α-synuclein mutation causes a novel Parkinsonian-pyramidal syndrome. Ann Neurol 2013;73:459-471.
7. Kiely AP, Asi YT, Kara E, et al. α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy? Acta Neuropathol 2013;125:753-769.
8. Pasanen P, Myllykangas L, Siitonen M, et al. Novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology. Neurobiol Aging 2014;35:2180. e1-e5.
9. Ghosh D, Sahay S, Ranjan P, et al. The newly discovered Parkinson's disease associated Finnish mutation (A53E) attenuates α-synuclein aggregation and membrane binding. Biochemistry 2014;53:6419-6421.
10. Goizet C, Boukhris A, Mundwiller E, et al. Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10. Hum Mutat 2009;30:E376-E385.
11. Martikainen MH, Päivärinta M, Hietala M, Kaasinen V. Novel SNCA mutation causes autosomal dominant Parkinson's disease [abstract]. Mov Disord 2014;29 (suppl 1):153.